1 control of glycogen metabolism - PowerPoint PPT Presentation

1 / 9
About This Presentation
Title:

1 control of glycogen metabolism

Description:

Glycogen phosphorylase inhibitors as potential antidiabetic drugs ... Dr. Virginia L. Rath, Dept. of Explor. Med. Sciences, Pfizer Inc., USA ... – PowerPoint PPT presentation

Number of Views:173
Avg rating:3.0/5.0
Slides: 10
Provided by: Inst63
Category:

less

Transcript and Presenter's Notes

Title: 1 control of glycogen metabolism


1
Protein Structure, Function Regulation
Programme
Research Activities
  • (1) control of glycogen metabolism
  • (2) control of neuromuscular transmission
  • Glycogen phosphorylase inhibitors as potential
    antidiabetic drugs
  • Structure and function of phosphorylase kinase
  • Crystallographic studies on Fab fragments of mAbs
    against the MIR of AChR

2
Protein Structure, Function Regulation
Programme
Main Achievements
  • Structure and function of phosphorylase kinase
  • Role of Asp149 in binding and orientation of
    the substrate and in catalysis of phosphoryl
    transfer. Activation segment is necessary in
    order to recognise and present the protein
    substrate for catalysis.
  • Crystallographic studies on Fab fragments of
    mAbs against the MIR of AChR
  • Crystal structures of the Fab fragments of rat
    monoclonal antibodies, 192 and 198. Rational
    design of very high affinity mutants
  • Glycogen phosphorylase (GP) inhibitors as
    potential antidiabetic drugs

3
(No Transcript)
4
(No Transcript)
5
Protein Structure, Function Regulation
Programme
Achievements
  • 19 Publications (refereed)
  • 425 Citations
  • 4 Ph.D Theses
  • 11 Externally Funded Projects, 108.000.000 GRD
  • Collaboration with
  • Pfizer (USA)
  • Novo Nordisk (Denmark)
  • Aventis (Germany).

6
Protein Structure, Function Regulation
Programme
Perspectives(1)
  • Development of potential antidiabetic drugs
  • Specific inhibitors for calcium/calmodulin
    regulated kinases by knowledge based design and
    combinatorial chemistry
  • Rational Design of Ribonuclease Inhibitors
  • Structural Basis of Nicotinic Acetylcholine
    Receptor Function

7
Protein Structure, Function Regulation
Programme
Perspectives(2)
  • European Structural Biology Forum (ESBF)- to a
    European infrastructure co-operation network
    (European Research Infrastructures Users)
  • Equipment for Structural Biology
  • Crystallisation room
  • 3 Silicon Graphics O2 Workstations
  • High-end V-Class V2600 supercomputer
  • Image Plate R-AXIS IV, CDSB, SRS, DESY, ELETTRA

8
Protein Structure, Function Regulation
Programme
Staff
Nikos G. Oikonomakos, Head Spyros E.
Zographos, Post-doc Katerina E. Tsitsanou, Res.
Assistant Vicky T. Skamnaki, Res. Assistant Eleni
Averkiou, technician
9
Protein Structure, Function Regulation
Programme
Collaborations
  • Prof. Louise N. Johnson, Lab. of Molecular
    Biophysics, Univ. of Oxford
  • Prof. George W.J. Fleet, Dyson Perrins
    Laboratory, Univ. of Oxford
  • Prof. Socrates J. Tzartos, Biochemistry Dept.,
    Hellenic Pasteur Instit., Athens
  • Prof. Costantinos Sakarellos, Dept. of
    Chemistry, Univ. of Ioannina
  • Dr. Patricia T.W. Cohen, Dept. of Biochemistry,
    Univ. of Dundee
  • Prof. David Barford, Struct. Biology Section,
    Inst. of Cancer Research, London
  • Prof. G. Eisenbrand, Fachbereich Chemie, Univ.
    Kaiserslautem
  • Prof. G. Archontis, Dept. of Physics, Univ. of
    Cyprus
  • Prof. Martin Karplus, Dept. of Chemistry Chem.
    Biol., Harvard Univ
  • Dr. Virginia L. Rath, Dept. of Explor. Med.
    Sciences, Pfizer Inc., USA
Write a Comment
User Comments (0)
About PowerShow.com